Anti-obesity Drugs Market in the US 2015-2019

About Obesity
Obesity is a complex multifactorial disorder characterized by the excessive accumulation and storage of fat in the body. In the recent years, this chronic illness is being considered as a global epidemic owing to its strikingly increasing incidence rates, especially in the in low and middle-income countries. Sedentary lifestyles and lack of physical activity coupled with consumption of high-calorie diet are considered to be the most preventable causes of obesity. Being either overweight or obese is considered as a risk factor for the development of multiple chronic diseases including cardiovascular disorders such as coronary heart disease, dyslipidemia, hypertension; metabolic disorders such as diabetes; and cancers to highlight a few. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.

Technavio's analysts forecast the anti-obesity drugs market in the US to grow at a CAGR of 24.52% over the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the anti-obesity drugs market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of the currently approved patented drugs, generics, OTC products, and the available generics that are used for the treatment of obesity.

Technavio's report, Anti-obesity Drugs Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the
key vendors operating in this market.

Key Vendors
• Arena Pharmaceuticals
• F. Hoffmann-La Roche 
• GlaxoSmithKline 
• Novo Nordisk
• Orexigen Therapeutics
• Vivus

Other Prominent Vendors
• Alizyme 
• Amylin
• Boehringer Ingelheim 
• Eisai 
• Merck 
• Norgine 
• Pfizer
• Rhythm Pharmaceuticals 
• Shionogi USA 
• Takeda Pharmaceutical
• Zafgan

Key Market Driver
• Growing Prevalence Population 
• For a full, detailed list, view our report

Key Market Challenge
• Serious Adverse Events and Multiple Drug Withdrawals
• For a full, detailed list, view our report

Key Market Trend
• Diversification of Investigational Pipeline 
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?